Pemetrexed-Resistant Non-Small Cell Lung Cancer Cell Lines Have Novel Drug-Resistant Mechanisms

被引：0
|
作者：
Tanino, R. [1 ]
Tsubata, Y. [2 ]
Harashima, N. [3 ]
Harada, M. [4 ]
Isobe, T. [2 ]
机构：
[1] Shimane Univ, Div Med Oncol & Resp Med, Dept Internal Med, Izumo, Shimane, Japan
[2] Shimane Univ, Div Med Oncol & Resp Med, Izumo, Shimane, Japan
[3] Univ Ryukyus, Fac Med, Lab Biometab Chem, Sch Hlth Sci, Nishihara, Okinawa, Japan
[4] Shimane Univ, Fac Med, Dept Immunol, Izumo, Shimane, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
pemetrexed; drug resistance; EGFR-TKI;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.02-069
引用
收藏
页码：S1949 / S1949
页数：1
相关论文
共 50 条
  • [31] CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer
    Thiruvalluvan, Manish
    Billet, Sandrine
    Liu, Zhenqiu
    Lownik, Joseph
    Waissengrin, Barliz
    Kim, Hyoyoung
    Villamejor, Anton L.
    Milshteyn, Larry
    Li, Xiamo
    Gayhart, Matthew
    Arana, Manuel
    Sankar, Kamya
    Posadas, Edwin M.
    Lopategui, Jean
    You, Sungyong
    Reckamp, Karen L.
    Bhowmick, Neil A.
    DRUG RESISTANCE UPDATES, 2025, 81
  • [32] Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer
    Wang, Yi-Ting
    Pan, Szu-Hua
    Tsai, Chia-Feng
    Kuo, Ting-Chun
    Hsu, Yuan-Ling
    Yen, Hsin-Yung
    Choong, Wai-Kok
    Wu, Hsin-Yi
    Liao, Yen-Chen
    Hong, Tse-Ming
    Sung, Ting-Yi
    Yang, Pan-Chyr
    Chen, Yu-Ju
    SCIENTIFIC REPORTS, 2017, 7
  • [33] Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data
    Nagarajan, Nagasundaram
    Guda, Chittibabu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] Covalent Epidermal Growth Factor Receptor (EGFR) Inhibitors in Targeted Therapy of Drug-Resistant Non-Small Cell Lung Cancer (A Review)
    Shvetsov, A. B.
    Semenov, A. V.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2024, 50 (06) : 2283 - 2311
  • [35] Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer
    Yi-Ting Wang
    Szu-Hua Pan
    Chia-Feng Tsai
    Ting-Chun Kuo
    Yuan-Ling Hsu
    Hsin-Yung Yen
    Wai-Kok Choong
    Hsin-Yi Wu
    Yen-Chen Liao
    Tse-Ming Hong
    Ting-Yi Sung
    Pan-Chyr Yang
    Yu-Ju Chen
    Scientific Reports, 7
  • [36] Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance Protein
    Lin, Chia-Yi
    Wu, Hsin-Yi
    Hsu, Yuan-Ling
    Cheng, Ting-Jen Rachel
    Liu, Jyung-Hurng
    Huang, Rou-Jie
    Hsiao, Tzu-Hung
    Wang, Chia-Jen
    Hung, Pei-Fang
    Lan, Albert
    Pan, Szu-Hua
    Chein, Rong-Jie
    Wong, Chi-Huey
    Yang, Pan-Chyr
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (06) : 3172 - 3187
  • [37] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [38] The role of brigatinib in crizotinib-resistant non-small cell lung cancer
    Mezquita, Laura
    Planchard, David
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 123 - 130
  • [39] The activity of 2′-benzoyloxycinnamaldehyde against drug-resistant cancer cell lines
    Chung, Young Min
    Do Yoo, Young
    Kim, Jun Suk
    Lee, Chang Youl
    Kim, Hyung Jung
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 428 - 437
  • [40] The significance of lumican expression in ovarian cancer drug-resistant cell lines
    Klejewski, Andrzej
    Sterzynska, Karolina
    Wojtowicz, Karolina
    Swierczewska, Monika
    Partyka, Malgorzata
    Brazert, Maciej
    Nowicki, Michal
    Zabel, Maciej
    Januchowski, Radoslaw
    ONCOTARGET, 2017, 8 (43) : 74466 - 74478
12345